Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 24Uterine Cervical Neoplasms 18Fallopian Tube Neoplasms 15Endometrial Neoplasms 13Neoplasm Metastasis 9Breast Neoplasms 9Pancreatic Neoplasms 8Uterine Cervical Dysplasia 6Melanoma 6Colorectal Neoplasms 6Prostatic Neoplasms 5Stomach Neoplasms 4Precancerous Conditions 4Carcinosarcoma 4Carcinoma, Renal Cell 4Vulvar Neoplasms 3Uterine Neoplasms 3Urinary Bladder Neoplasms 3Triple Negative Breast Neoplasms 3Squamous Intraepithelial Lesions 3Sarcoma 3Salivary Gland Neoplasms 3Neoplasms 3Carcinoma, Ovarian Epithelial 3Carcinoma, Non-Small-Cell Lung 3Anus Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Skin Neoplasms 2Rectal Neoplasms 2Papillomavirus Infections 2

Interventions

fludarabine phosphate 1fludarabine 1artesunic acid 1artenimol 1artemisinin 1aldesleukin 1Respiratory Function Tests 1Prochlorperazine 1Positron-Emission Tomography 1Ondansetron 1O(6)-codeine methyl ether 1Meperidine 1Magnetic Resonance Imaging 1Loperamide 1Interleukin-2 1Innovar 1Indomethacin 1Hydroxyzine 1Granisetron 1Electrocardiography 1Droperidol 1Doxylamine 1Diphenoxylate 1Diphenhydramine 1Cyclophosphamide 1Codeine 1Cell Count 1Biopsy 1Atropine 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Vulvar Diseases × Biopsy × Gynecologic × Clear all
NCT02858310 2026-03-09

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
224 enrolled 15 charts
Gynecologic

Carcinoma in Situ, Uterine Cervical Dysplasia, Vulvar Diseases, Vulvar Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡